EGM Statement

Mercury Group PLC 11 January 2007 11 January 2007 Mercury Group plc ('Mercury' or the 'Company') EGM Statement At the Extraordinary General Meeting of Mercury to be held at 10.00 a.m. this morning the Chairman of the Company will make the following statement: 'In the circular sent to shareholders on 15 December 2006, the Senior Independent Director stated that the board anticipated that the results for the year ended 30 September 2006 would show material losses and that the Group was performing below expectations. I can report that trading of the Mercury Group for the first quarter of the current financial year was marginally ahead of management expectations due to a substantial one-off project being invoiced in late December. The Directors of Mercury, in conjunction with their advisers, considered carefully the requirement for further equity capital before determining the amount to be sought from shareholders under the current placing and open offer. The directors consider that, in order to create shareholder value, further investment in the group's core business, Smith Melzack Pepper Angliss Limited ('SMPA'), is necessary to enable it to grow to a critical mass. The funds being raised from the placing and open offer will be used for the following purposes: - to pay overdue creditors of the Group; - to recruit additional personnel to increase income and improve management succession; - to invest and develop the SMPA infrastructure and brand name; - to provide an adequate headroom to satisfy AIM Rules; and - to pay the costs of the fund raising. I would like to reemphasise a statement made in the circular to shareholders, the essence of which is that should the proposals not be approved by shareholders, trading in the Company's shares will be suspended on AIM and the Directors would have to seek financial advice from an insolvency practitioner regarding their obligations.' For enquiries: Mercury Group plc 020 7393 4001 Walter Goldsmith (non-executive chairman) John East & Partners Limited John East/David Worlidge 020 7628 2200 College Hill Associates 020 7457 2020 Matthew Smallwood This information is provided by RNS The company news service from the London Stock Exchange

Companies

Medica Group (MGP)
UK 100

Latest directors dealings